Results 201 to 210 of about 671,308 (289)

A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D. [PDF]

J Clin Microbiol
Lopes TB, Coelho FF, Roca TP, Oliveira JKA, Delagarde V, Brichler S, Gómez Mendoza DP, Villalobos Salcedo JM, Vieira DS, Le Gal F, Gazzinelli RT, Fernandes AP.   +11 more
europepmc   +1 more source

Infection Risk From Humans and Animals in the Anatomy Laboratory: A Scoping Review

Clinical Anatomy, EarlyView.
ABSTRACT Whole‐body dissection is a cornerstone of anatomy education. During and following the COVID‐19 pandemic, exposure to infectious agents and other risks of dissection were highlighted. To identify potential risks, one must have the data outlining these risks in specific situations.
Margaret A. McNulty, Elizabeth R. Agosto
wiley   +1 more source

The Prevalence and Risk Factors of Hepatitis B, Hepatitis C, and Hepatitis D Coinfection in Iran's General Population Over the Past 25 Years: A Systematic Review and Meta-Analysis. [PDF]

J Epidemiol Glob Health
Naderi M, Kordkatuli K, Makokha GN, Moradi A, Mehravar F, Hijikata M, Chayama K.   +6 more
europepmc   +1 more source

The successful implementation of Scotland's Hepatitis C Action Plan:what can other European stakeholders learn from the experience? A Scottish voluntary sector perspective. [PDF]

, 2014
D Griesbach, David Liddell, European Centre for Disease Prevention and Control and European Monitoring Centre for Drugs and Drug Addiction, JK Champion, KM Turner, Leon Wylie, M Chisholm, Nicola Rowan, R Robertson, S Hutchinson, S Hutchinson, S McDonald, Scottish Drugs Forum, Scottish Government, Sharon Hutchinson, SJ Hutchinson   +15 more
core   +3 more sources

Lipid Profile Differences in HIV‐Infected Populations With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis

Chronic Diseases and Translational Medicine, EarlyView.
PRISMA study flow diagram. ABSTRACT Introduction Advances in HIV management have transformed HIV into a chronic condition, resulting in improved prognosis and increased survival among people living with HIV (PLWH). Traditional risk factors for metabolic dysfunction‐associated steatotic liver disease (MASLD)—including dyslipidemia—are prevalent in PLWH.
Yovita Hartantri, Sherly Lawrensia, Steven Yulius Usman, Nenny Agustanti, Rudi Wisaksana, Nanny Natalia Mulyani Soetedjo, Bachti Alisjahbana   +6 more
wiley   +1 more source

Hepatitis B virus and hepatitis D virus co-infection complicated by autoimmune hepatitis: Two case reports. [PDF]

World J Clin Cases
Dou J, Zhao XY, Wang ZG, Ning ZH, Wang XZ, Guo F.   +5 more
europepmc   +1 more source

Burden of Liver Disease Among Individuals With Turner Syndrome and Klinefelter Syndrome: A Comprehensive Perspective

Chronic Diseases and Translational Medicine, EarlyView.
ABSTRACT The liver is increasingly recognized as a major regulator of systemic cardio‐renal‐metabolic health. Evidence is mounting that sex‐chromosome dosage per se itself, independent of gonadal sex hormones, modulates hepatic physiology and liver disease risk.
Mohamad Jamalinia, Amedeo Lonardo, Ralf Weiskirchen   +2 more
wiley   +1 more source

Frequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in Hepatitis D Infection. [PDF]

J Viral Hepat
Hardtke S, Yurdaydin C, Caruntu FA, Curescu MG, Yalcin K, Akarca US, Gürel S, Zeuzem S, Erhardt A, Lüth S, Papatheodoridis GV, Port K, Manns MP, Cornberg M, Kahlhöfer J, Wedemeyer H.   +15 more
europepmc   +1 more source

Conformational Trajectory of the Molecular Chameleon Grazoprevir from Formulation to Target‐Bound

Chemistry – A European Journal, EarlyView.
ABSTRACT Macrocycles represent a promising class of beyond‐rule‐of‐5 (bRo5) therapeutics, capable of targeting proteins traditionally considered undruggable by conventional small molecules. Macrocycles exhibit intrinsic flexibility and often display a “chameleon‐like” ability to adapt to their environment, thereby enhancing their oral bioavailability ...
Lianne H. E. Wieske, Guanhong Bu, Máté Erdélyi, Jan Kihlberg, Tamir Gonen, Emma Rova Danelius   +5 more
wiley   +1 more source

Ten-Year Follow-Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT-II): Improved Clinical Outcome After Combination Therapy. [PDF]

United European Gastroenterol J
Yurdaydin C, Kahlhöfer J, Caruntu FA, Yalcin K, Gürel S, Akarca US, Sprinzl K, Bock HH, Bockmann JH, Papatheodoridis GV, Merle U, Demir M, Hardtke S, Keskin O, Idilman R, Cornberg M, Wedemeyer H, Wranke A.   +17 more
europepmc   +1 more source